Kishore Lalit, Singh Randhir
M.M. College of Pharmacy, M.M. University, Mullana-Ambala, Haryana 133207, India.
M.M. College of Pharmacy, M.M. University, Mullana-Ambala, Haryana 133207, India.
J Ayurveda Integr Med. 2019 Oct-Dec;10(4):255-261. doi: 10.1016/j.jaim.2017.07.010. Epub 2018 Nov 16.
Diabetic nephropathy (DN) is the foremost cause of morbidity and has become the most recurrent cause of end-stage renal disease among diabetic patients. Thus, agents having antidiabetic effect along with safety potential in the kidneys would have a higher remedial value.
The present study aimed to investigate possible protective effect of homeopathic preparation of Cephalandra indica Mother tincture, 6C and 30 C potencies on DN in Wistar rats.
DN was induced by intraperitoneal injection of STZ (60 mg/kg) 15 min after Nicotinamide (230 mg/kg, i.p.) administration. Rats were divided into six groups (n = 6). Group 1 and 2 was kept normal control and diabetic control respectively whereas Groups 3-5 consist of diabetic nephropathy rats treated with different doses of C. indica Mother tincture, 6C and 30 C potencies for 45 days. Glimepride (10 mg/kg) was used as standard. DN was assessed by determining serum glucose, urea, uric acid, creatinine level and tissue histological examination. Tissue antioxidant enzymes (SOD, GSH, LPO) level was measured to assess the oxidative stress. Also, the level of advanced glycation end products in kidney was determined.
Mother tincture, 6C and 30 C potencies of C. indica produced significant attenuation in the biochemical parameters used to assess diabetic nephropathy. Moreover, oxidative stress and AGE's level in kidney was also found to be significantly reduced.
We conclude that Mother tincture, 6C and 30 C potencies of C. indica confers protective effect against diabetic nephropathy via inhibition of Oxidative stress and AGE's.
糖尿病肾病(DN)是发病的首要原因,已成为糖尿病患者终末期肾病最常见的病因。因此,具有抗糖尿病作用且对肾脏有潜在安全性的药物具有更高的治疗价值。
本研究旨在探讨印度栝楼母酊剂、6C和30C药力的顺势疗法制剂对Wistar大鼠糖尿病肾病的可能保护作用。
在腹腔注射烟酰胺(230mg/kg)15分钟后,腹腔注射链脲佐菌素(60mg/kg)诱导糖尿病肾病。将大鼠分为六组(n = 6)。第1组和第2组分别作为正常对照组和糖尿病对照组,而第3 - 5组由用不同剂量的印度栝楼母酊剂、6C和30C药力治疗45天的糖尿病肾病大鼠组成。格列美脲(10mg/kg)用作标准对照。通过测定血清葡萄糖、尿素、尿酸、肌酐水平和组织组织学检查来评估糖尿病肾病。测量组织抗氧化酶(超氧化物歧化酶、谷胱甘肽、脂质过氧化)水平以评估氧化应激。此外,还测定了肾脏中晚期糖基化终产物的水平。
印度栝楼母酊剂、6C和30C药力显著降低了用于评估糖尿病肾病的生化参数。此外,还发现肾脏中的氧化应激和晚期糖基化终产物水平显著降低。
我们得出结论,印度栝楼母酊剂、6C和30C药力通过抑制氧化应激和晚期糖基化终产物对糖尿病肾病具有保护作用。